|
InfiniteBio offers comprehensive consultancy services to support partnering activities between US and Japanese companies/institutes. InfiniteBio's core strength includes strong relationships with key players in the Japanese pharmaceutical industry and strong relationships with various US companies, ranging from small startups to large pharmaceutical companies.
 |
Examples of opportunities |
 |
Drug seeds from Japanese research institutes |
|
Drugs available for licensing from major Japanese pharmaceutical companies |
|
Novel animal models developed in Japanese research institutes |
|
Novel therapeutic targets found in Japanese research institutes |
|
Access to Japanese academic research projects - Examples include a screening assay service and collaboration research |
|
Service |
Comprehensive solution: Opportunity identification through deal closure
 - Opportunity Identification
We identify potential licensing opportunities suitable for your needs by utilizing our internal/external database and extensive licensing contacts.
We create an optimal list of potential partners based on your needs, such as development phase, agent type, therapeutic area, mechanism of action, type of partner, and type of alliance.
- Partner Connection
We then contact potential partners from a list of opportunities and bring them into active discussions. We support arrangement of confidential disclosure agreements for deeper discussion, arrange meetings, and provide communication support at the meeting, if necessary.
We also support generation of information packages and presentation materials, with Japanese language support when necessary.
- Deal-making Support
While evaluating and meeting with potential partners, we support you in your deal negotiations. We provide you flexible support based on your needs.
|
Licensing examples |
- Drug in-license support from Japan to the US
InfiniteBio identifies drug in-licensing opportunities from Japanese pharmaceutical companies and research institutes based on the American company's needs.
- Drug and technology transfer from Japan to the US
InfiniteBio introduces drugs and technologies developed in Japan to global companies in cooperation with Japanese universities and research institutes.
- Drug out-license support from the US to Japan
InfiniteBio identifies suitable Japanese companies to out-license drugs developed in the US using strong networks with Japanese and US companies.
|
Service Fee |
We work on a retainer and a success fee basis. Our diverse range of fee systems provides you with flexible services based on your budget. We will work closely with you to understand and realize your goals for the project.
All work is pursuant to pre-agreed contractual terms.
|
